The manipulation of pluripotent stem cells to generate specific cell types is key to the application of these cells to the treatment of disease. Our researchers have developed methods for the expansion of populations of human pluripotent cells and subsequent differentiation into mesoderm and endoderm progenitors using chemically defined media that does not require the use of stroma cells or animal serum, thus avoiding a key barrier to the use of these cells in the clinic.

« Back to all licences